Drug · DIN 02361817
BYETTA
2.4 ML PREFILLED PEN 60 DOSES OF 10¿CG/DOSE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 1, 2022; first marketed May 31, 2011.
- Drug Identification Number (DIN)
- 02361817
- Company (DIN owner)
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Exenatide A10BJ01
- Class
- Human
- Record last updated
- July 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EXENATIDE | 10 MCG | ACT |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 30, 2014: NOC 15784New Drug Submission (NDS) · Transfer of drug identification numbers
- August 1, 2013: NOC 14623New Drug Submission (NDS) · Administrative transfer of drug identification number
- January 13, 2011: NOC 11997New Drug Submission (NDS)
Other DINs named BYETTA
- DIN 02361809 · Cancelled Post Market